Additionally, RBMX inhibits aerobic glycolysis via hnRNP-A1-dependent PKM alternative splicing, and it counteracts the aggressive phenotype induced by PKM2 overexpression in bladder cancer cells (31). Here, PKM is linked to urinary bladder carcinoma.